What is the price of Mind Medicine (mmedf) stock?
Apr 02, 2022 · Medifast Stock Forecast, Price & News $184.06 -0.87 (-0.47%) (As of 04/14/2022 12:00 AM ET) Today's Range $182.00 $186.31 50-Day Range $163.59 $196.12 52-Week Range $161.44 $336.99 Volume 68,072 shs Average Volume 123,901 shs Market Capitalization $2.12 billion P/E Ratio 13.25 Dividend Yield 3.55% Beta 1.41 Profile Analyst Ratings Chart
What is Mind Medicine (mindmed)'s stock symbol?
Medifast (MED) New York Stock Exchange MED $184.06 -$0.87 -0.5% Price as of April 14, 2022, 4:00 p.m. ET View Interactive MED Charts The Company is engaged in the production, …
Where can I buy med shares?
MED | Complete Medifast Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
What is the target price for Medifast stock?
Apr 08, 2022 · View MEDIFAST INC MED investment & stock information. Get the latest MEDIFAST INC MED detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.
What sector is Medifast in?
MiscellaneousKey DataLabelValueSectorMiscellaneousIndustryOther Consumer Services1 Year Target$343.00Today's High/Low$186.31/$182.0014 more rows
Can I buy Medifast stock?
Buy Medifast shares from these brokerages Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN. Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
Is Med a good stock to buy?
Medifast has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
Is Optavia on the stock exchange?
BALTIMORE, Feb. 27, 2020 /PRNewswire/ -- Medifast (NYSE: MED), the company behind one of the fastest-growing health and wellness communities, OPTAVIA®, today announced it will ring The Opening Bell® at the New York Stock Exchange (NYSE) on March 2, 2020, in celebration of its strong 2019 revenue and earnings results.Feb 27, 2020
What is Medifast company?
Medifast, Inc. (NYSE: MED) is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.
Should I buy mind medicine stock?
Mind Medicine (MindMed) Inc (MNMD) stock is down -53.44% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver's proprietary ranking system, gives MNMD stock a score of 31 out of a possible 100. That rank is influenced by a long-term technical score of 6.Dec 31, 2021
Why is MindMed stock going down?
The recent decline in MindMed's share price is a result of changes to the broader macroeconomic landscape. The FDA just approved MindMed's IND application, inducing a spike in the company's shares. Still, MindMed is down 67% in the past year.Jan 27, 2022
Is MindMed profitable?
MidMed Has Cash, But No Revenue or Profits Yet As of fiscal year (FY) 2020, the company has zero debt. MindMed had a lot more cash on its balance sheet in FY 2020 compared to FY 2019.Jul 8, 2021
Where are Medifast products manufactured?
Jason Pharmaceuticals, Inc., the Company's wholly-owned subsidiary, manufactures and produces all Medifast powder-based products, which is approximately 42% of Medifast's product revenues, in the manufacturing facility in Owings Mills, Maryland.
Is Medifast a buy right now?
2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Medifast in the last twelve months. There are currently 2 buy rat...
How has Medifast's stock price been impacted by Coronavirus (COVID-19)?
Medifast's stock was trading at $70.44 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organi...
When is Medifast's next earnings date?
Medifast is scheduled to release its next quarterly earnings announcement on Tuesday, May 3rd 2022. View our earnings forecast for Medifast .
How were Medifast's earnings last quarter?
Medifast, Inc. (NYSE:MED) issued its quarterly earnings data on Wednesday, February, 23rd. The specialty retailer reported $2.91 earnings per share...
How often does Medifast pay dividends? What is the dividend yield for Medifast?
Medifast announced a quarterly dividend on Thursday, December 9th. Stockholders of record on Tuesday, December 21st will be paid a dividend of $1.4...
Is Medifast a good dividend stock?
Medifast pays an annual dividend of $5.68 per share and currently has a dividend yield of 3.47%. Medifast has been increasing its dividend for 4 co...
What guidance has Medifast issued on next quarter's earnings?
Medifast updated its FY 2022 earnings guidance on Wednesday, March, 9th. The company provided earnings per share guidance of $14.500-$16.000 for th...
What price target have analysts set for MED?
2 brokers have issued 1 year target prices for Medifast's stock. Their forecasts range from $341.00 to $400.00. On average, they expect Medifast's...
Who are Medifast's key executives?
Medifast's management team includes the following people: Daniel R. Chard , Executive Chairman & Chief Executive Officer ( LinkedIn Profile ) Ja...
Is Medifast a buy right now?
What stocks does MarketBeat like better than Medifast?
3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medifast in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Medifast stock.#N#View analyst ratings for Medifast or view top-rated stocks.
Are investors shorting Medifast?
Wall Street analysts have given Medifast a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Medifast wasn't one of them.
When is Medifast's next earnings date?
Medifast saw a increase in short interest in July. As of July 15th, there was short interest totaling 391,800 shares, an increase of 17.2% from the June 30th total of 334,200 shares. Based on an average trading volume of 113,700 shares, the short-interest ratio is presently 3.4 days.
How were Medifast's earnings last quarter?
Medifast is scheduled to release its next quarterly earnings announcement on Monday, November 1st 2021.#N#View our earnings forecast for Medifast.
How has Medifast's stock been impacted by Coronavirus?
Medifast, Inc. (NYSE:MED) issued its earnings results on Wednesday, August, 4th. The specialty retailer reported $3.96 earnings per share for the quarter, beating the consensus estimate of $3.30 by $0.66. The specialty retailer had revenue of $394.20 million for the quarter, compared to the consensus estimate of $359.25 million.
How often does Medifast pay dividends? What is the dividend yield for Medifast?
Medifast's stock was trading at $70.44 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, MED shares have increased by 229.7% and is now trading at $232.21.#N#View which stocks have been most impacted by COVID-19.
Recently Viewed Tickers
Medifast declared a quarterly dividend on Thursday, June 3rd. Shareholders of record on Tuesday, June 22nd will be paid a dividend of $1.42 per share on Friday, August 6th. This represents a $5.68 dividend on an annualized basis and a dividend yield of 2.45%.
Medifast Inc
Visit a quote page and your recently viewed tickers will be displayed here.
Key Earnings Data
Medifast, Inc. is a health and wellness company, which engages in the manufacture and distribution of healthy living products and programs. Its platform include OPTAVIA, it offers lifelong transformation and one healthy habit at a time. The company was founded by William Vitale in 1980 and is headquartered in Baltimore, MD.
Conagra (CAG) Troubled by Escalated Costs & Divestitures
Zacks Earnings ESP (Expected Surprise Prediction) looks to find companies that have recently seen positive earnings estimate revision activity. The idea is that more recent information is, generally speaking, more accurate and can be a better predictor of the future, which can give investors an advantage in earnings season.
MediBloc MED
Rowland & Co Investment Counsel Buys Verizon Communications Inc, Discover Financial ...
MED Price Live Data
Change the wallet network in the MetaMask Application to add this contract.
Is Mind Medicine (MindMed) a buy right now?
The live MediBloc price today is $0.078461 USD with a 24-hour trading volume of $80,269,254 USD. We update our MED to USD price in real-time. MediBloc is down 15.97% in the last 24 hours. The current CoinMarketCap ranking is #145, with a live market cap of $422,307,387 USD. It has a circulating supply of 5,382,401,140 MED coins and the max.
What stocks does MarketBeat like better than Mind Medicine (MindMed)?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Mind Medicine (MindMed) in the last twelve months. There are currently 1 buy rating for the stock.
How has Mind Medicine (MindMed)'s stock price been impacted by Coronavirus?
Wall Street analysts have given Mind Medicine (MindMed) a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Mind Medicine (MindMed) wasn't one of them.
What price target have analysts set for MMEDF?
Mind Medicine (MindMed)'s stock was trading at $0.35 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, MMEDF stock has increased by 685.7% and is now trading at $2.75.#N#View which stocks have been most impacted by COVID-19.
Who are some of Mind Medicine (MindMed)'s key competitors?
1 equities research analysts have issued 1-year price targets for Mind Medicine (MindMed)'s shares. Their forecasts range from $2.00 to $2.00. On average, they anticipate Mind Medicine (MindMed)'s share price to reach $2.00 in the next twelve months.
What is Mind Medicine (MindMed)'s stock symbol?
Some companies that are related to Mind Medicine (MindMed) include (TNGN) (TNGN), 3SBio (TRSBF), 45525 (CUR.TO) (CUR), Abattis Bioceuticals (ATTBF), Abzena (ABZA), Acrux (ACR), Actinogen Medical (ACW), AdAlta (1AD), Admedus (AHZ), Algernon Pharmaceuticals (AGNPF), Almirall (LBTSF), Amarantus BioScience (AMBS), Amplia Therapeutics (ATX), Anatara Lifesciences (ANR) and Annovis Bio (ANVS).#N#View all of MMEDF's competitors..
How do I buy shares of Mind Medicine (MindMed)?
Mind Medicine (MindMed) trades on the OTCMKTS under the ticker symbol "MMEDF."
Recently Viewed Tickers
Shares of MMEDF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.#N#Compare Top Brokerages Here.
Mind Medicine (MindMed) Inc
Visit a quote page and your recently viewed tickers will be displayed here.
